biomark tm system Search Results


90
Oxford Cancer Biomarkers toxnav tm germline dna sequencing-based test
Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the <t> ToxNav </t> test
Toxnav Tm Germline Dna Sequencing Based Test, supplied by Oxford Cancer Biomarkers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biomark+tm+system/toxnav+tm+germline+dna+sequencing+based+test/pmc06797583-173-7-0
Average 90 stars, based on 1 article reviews
toxnav tm germline dna sequencing-based test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bioventure Consulting GmbH biomarker tm low
Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the <t> ToxNav </t> test
Biomarker Tm Low, supplied by Bioventure Consulting GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biomark+tm+system/biomarker+tm+low/pm23635087-51-0-3
Average 90 stars, based on 1 article reviews
biomarker tm low - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Biomark Inc biomark microchips tm
Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the <t> ToxNav </t> test
Biomark Microchips Tm, supplied by Biomark Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biomark+tm+system/biomark+microchips+tm/brown_catherine__2023__evidence_based_conservation_of_rare_and_endangered_amphibians_in_california_s_sierra_nevada-1600-24-27
Average 86 stars, based on 1 article reviews
biomark microchips tm - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the  ToxNav  test

Journal: Cancer Medicine

Article Title: ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study

doi: 10.1002/cam4.2529

Figure Lengend Snippet: Risk classification criteria for assigning a risk classification to patients based on the genetic sequencing results from the ToxNav test

Article Snippet: Oxford Cancer Biomarkers Limited (OxfordBio) developed the ToxNav TM germline DNA sequencing‐based test.

Techniques: Sequencing

 Germline  variants analyzed in the  ToxNav  test and frequencies observed in the PRECISE clinical cohort

Journal: Cancer Medicine

Article Title: ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study

doi: 10.1002/cam4.2529

Figure Lengend Snippet: Germline variants analyzed in the ToxNav test and frequencies observed in the PRECISE clinical cohort

Article Snippet: Oxford Cancer Biomarkers Limited (OxfordBio) developed the ToxNav TM germline DNA sequencing‐based test.

Techniques: Variant Assay